Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Dental Materials : Official Publication of the Academy of Dental Materials|October 15, 2023
Dental implant material related changes in molecular signatures in peri-implantitis - A systematic review of omics in-vivo studiesThomas Spinell, Annika Kröger, Lena Freitag, et al.
Annals of Hematology|December 4, 2014
A multi-state model approach for prediction in chronic myeloid leukaemiaMichael Lauseker, Joerg Hasford, Verena S Hoffmann, et al.
Epilepsia|June 22, 2020
Who seizes longest? Impact of clinical and demographic factorsElisabeth Kaufmann, Magdalena Seethaler, Michael Lauseker, et al.
Acta Neuropathologica Communications|March 5, 2021
The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agentsSebastian Siller, Michael Lauseker, Philipp Karschnia, et al.
European Journal of Haematology|July 17, 2019
Differences in treatment and monitoring of chronic myeloid leukemia with regard to age, but not sex: Results from a population-based studyMichael Lauseker, Roman Gerlach, Wenke Worseg, et al.
Clinical Neurology and Neurosurgery|July 16, 2023
The impact of initial counselling for patients' decision-making and the accuracy of interdisciplinary neurovascular board evaluation in elective treatment of unruptured intracranial aneurysms - a German single-centre retrospective studySebastian Siller, Mathias Kunz, Michael Lauseker, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|December 16, 2022
Dental implant material related changes in molecular signatures in peri-implantitis - A systematic review and integrative analysis of omics in-vitro studiesLena Freitag, Thomas Spinell, Annika Kröger, et al.
Acta Neurologica Scandinavica|October 4, 2020
Hemispheric differences in the duration of focal onset seizuresMagdalena Seethaler, Michael Lauseker, Katharina Ernst, et al.
Leukemia & Lymphoma|December 7, 2021
SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatmentDamla Buket Egeli, Benjamin Hanfstein, Michael Lauseker, et al.
Cancer|February 14, 2017
Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature deathMichael Lauseker, Joerg Hasford, Susanne Saussele, et al.
Pageof 8